Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

The Tobacco Deposition and Trial Testimony Archive (DATTA) project: origins, aims, and methods.

Davis RM, Douglas CE, Beasley JK.

Tob Control. 2006 Dec;15 Suppl 4:iv4-8. Review.

2.

The role of tobacco advertising and promotion: themes employed in litigation by tobacco industry witnesses.

Goldberg ME, Davis RM, O'Keefe AM.

Tob Control. 2006 Dec;15 Suppl 4:iv54-67. Review.

3.

Challenging the epidemiologic evidence on passive smoking: tactics of tobacco industry expert witnesses.

Francis JA, Shea AK, Samet JM.

Tob Control. 2006 Dec;15 Suppl 4:iv68-76. Review.

4.

Potential reduced exposure products (PREPs) in industry trial testimony.

Wayne GF.

Tob Control. 2006 Dec;15 Suppl 4:iv90-7. Review.

5.

Tobacco industry lawyers as "disease vectors".

Guardino SD, Daynard RA.

Tob Control. 2007 Aug;16(4):224-8. Review.

6.

Tobacco industry litigation position on addiction: continued dependence on past views.

Henningfield JE, Rose CA, Zeller M.

Tob Control. 2006 Dec;15 Suppl 4:iv27-36. Review.

8.

Economics on trial: the use and abuse of economic methods in third party tobacco litigation.

Max W, Tsoukalas T.

Tob Control. 2006 Dec;15 Suppl 4:iv77-83. Review.

9.

Implications of the tobacco industry documents for public health and policy.

Bero L.

Annu Rev Public Health. 2003;24:267-88. Review.

PMID:
12415145
11.

Open doorway to truth: legacy of the Minnesota tobacco trial.

Hurt RD, Ebbert JO, Muggli ME, Lockhart NJ, Robertson CR.

Mayo Clin Proc. 2009 May;84(5):446-56. doi: 10.1016/S0025-6196(11)60563-6. Review.

12.

The saga of tobacco products liability litigation: a look back and a proposal for the future.

Nusbaum NJ.

J Community Health. 1998 Oct;23(5):325-35. Review.

PMID:
9793830
13.
14.

Secret science: tobacco industry research on smoking behaviour and cigarette toxicity.

Hammond D, Collishaw NE, Callard C.

Lancet. 2006 Mar 4;367(9512):781-7. Review.

PMID:
16517278
15.

The case for the plain packaging of tobacco products.

Freeman B, Chapman S, Rimmer M.

Addiction. 2008 Apr;103(4):580-90. doi: 10.1111/j.1360-0443.2008.02145.x. Review.

PMID:
18339104
16.
17.

Ethical implications of physician involvement in lawsuits on behalf of the tobacco industry.

Alderman J.

J Law Med Ethics. 2007 Winter;35(4):692-8, 513. Review.

PMID:
18076519
18.

The case for fire safe cigarettes made through industry documents.

Gunja M, Wayne GF, Landman A, Connolly G, McGuire A.

Tob Control. 2002 Dec;11(4):346-53. Review.

19.

The cigarette controversy.

Cummings KM, Brown A, O'Connor R.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1070-6. Review.

20.

Research gaps related to tobacco product marketing and sales in the Family Smoking Prevention and Tobacco Control Act.

Ribisl KM.

Nicotine Tob Res. 2012 Jan;14(1):43-53. doi: 10.1093/ntr/ntr098. Review.

PMID:
21690316

Supplemental Content

Support Center